PROLONGED DURATION AND DOSE OF METFORMIN THERAPY AND ITS ASSOCIATED EFFECT OF VITAMIN B12 DEFICIENCY AMONG TYPE II DM PATIENTS: A CROSS SECTIONAL STUDY.
Main Article Content
Keywords
Type II Diabetes Mellitus, Metformin, Vitamin B12, Peripheral neuropathy
Abstract
Objective: The aim of the study is to observe the long-term treatment of metformin and its associated effect on Vitamin B12 among Type II Diabetes mellitus south Indian patients.
Methods: An observational study conducted over a period of 54 months on Type II Diabetes mellitus patients who are in chronic therapy with metformin. The study described the Vitamin B12 levels among the Type II DM patients, which could alert the patients who are in the low and borderline range of serum Vitamin B12, which may prevent the risk of peripheral neuropathic complications and anaemic conditions, etc.
Findings: Totally, 387 patients were enrolled as per the inclusion and exclusion criteria, including 232 males (59.94%) and 155 females (40.05%). A total of 39 patients had been observed to have low levels of Vitamin B12, among them 23 females (Mean 184.17 ± S.D. 10.69) and 16 males (Mean 185.31± S.D 7.56), followed by 16 patients found to be above the normal range of Vitamin B12, among them 02 females (Mean 991 ± S.D. 15.55) and 14 males (Mean 1578.14 ± S.D. 406.93), followed by 76 patients had been found to be borderline of Vitamin B12, among them 43 females (Mean 220.76 ± S.D 6.50).
Conclusion: High doses of chronic Metformin therapy may alter Vitamin B12 levels. Some of the patients had an abnormally high level of serum Vitamin B12, whose medical condition should be ruled out, and such Patients’ diet histories were also cross-examined, which was a mixed normal diet, and they had various medical conditions. However, the high chances of metformin-associated effects on Vitamin B12 with higher doses and long-term therapy of metformin, whose duration was 10 to 20 years, Moreover, age is also an important factor, and the study reveals that, among genders, female populations had a higher rate of low-level Vitamin B12 than male populations. Patients in the age group between 50 and 65 years had a higher rate of low-level Vitamin B12 than other age groups, totaling 20 patients, among them 12 females (Mean 183.08 ± S.D. 13.17) and 8 males (Mean 185.5 ± S.D. 4.3). Patients with other comorbid conditions also had low levels and borderline levels of Vitamin B12 and had been on long-term metformin therapy. Therefore, our study concluded that chronic therapy and higher doses of metformin may lead to a deficit in serum Vitamin B12, which requires regular checks on Vitamin B12 among Type 2 DM patients to avoid the risk of Peripheral neuropathy and other complications.
References
2. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011 Jun;34(6):1249-1257.
3. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus present and future perspectives. Nat Rev Endocrinol 2011 Nov 8;8(4):228-236.
4. Lin Y, Sun Z. Current views on type 2 diabetes. J Endocrinol 2010 Jan;204(1):1-11.
5. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012 Jun;35(6):1364-1379.
6. Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.Diabetologia 2006 May;49(5):930-936.
7. Bell DS. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010 Mar;103(3):265-267.
8. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012 Mar;122(6):253-270.
9. Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2019, 157, 107843. [CrossRef] [PubMed]
10. Cho, N.H.; Shaw, J.E.; Karuranga, S.; Huang, Y.; da Rocha Fernandes, J.D.; Ohlrogge, A.W.; Malanda, B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018, 138, 271–281. [CrossRef] [PubMed]
11. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2009, 32 (Suppl. 1), S62–S67. [CrossRef] [PubMed]
12. Katsiki, N.; Ferrannini, E.; Mantzoros, C. New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician’s perspective. Metab. Clin. Exp. 2020, 17, 154218. [CrossRef]
13. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352, 854–865. [CrossRef]
14. Beedholm-Ebsen R, van de Wetering K, Hardlei T, Nexø E, Borst P, Moestrup SK. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood 2010; 115: 1632-1639 [PMID: 19897579 DOI: 10.1182/blood-2009-07-232587]
15. Seetharam B, Li N. Transcobalamin II and its cell surface receptor. Vitam Horm 2000; 59: 337-366 [PMID: 10714245 DOI: 10.1016/s0083-6729(00)59012-8]
16. Ankar A, Kumar A. Vitamin B12 Deficiency. 2020 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [PMID: 28722952]
17. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM, Yajnik C. Vitamin B12 deficiency. Nat Rev Dis Primers 2017; 3: 17040 [PMID: 28660890 DOI: 10.1038/nrdp.2017.40]
18. Beedholm-Ebsen R, van de Wetering K, Hardlei T, Nexø E, Borst P, Moestrup SK. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood 2010; 115: 1632-1639 [PMID: 19897579 DOI: 10.1182/blood-2009-07-232587]
19. Seetharam B, Li N. Transcobalamin II and its cell surface receptor. Vitam Horm 2000; 59: 337-366 [PMID: 10714245 DOI: 10.1016/s0083-6729(00)59012-8]
20. Ankar A, Kumar A. Vitamin B12 Deficiency. 2020 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [PMID: 28722952]
21. Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM, Yajnik C. Vitamin B12 deficiency. Nat Rev Dis Primers 2017; 3: 17040 [PMID: 28660890 DOI: 10.1038/nrdp.2017.40]
22. Konda M, Godbole A, Pandey S, Sasapu A. Vitamin B12 deficiency mimicking acute leukemia. Pro (Bayl Univ Med Cent) 2019; 32: 589-592 [PMID: 31656431 DOI: 10.1080/08998280.2019.1641045]
23. 23 Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol 2014; 120: 915- 926 [PMID: 24365360 DOI: 10.1016/B978-0-7020-4087-0.00060-7]
24. 24 Langan RC, Goodbred AJ. Vitamin B12 Deficiency: Recognition and Management. Am Fam Physician 2017; 96: 384-389 [PMID: 28925645]
25. Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? J Diabetes Metab Disord 2013; 12: 17 [PMID: 23651730 DOI: 10.1186/2251-6581-12-17]
26. Bell DS. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010; 103: 265-267 [PMID: 20134380 DOI: 10.1097/SMJ.0b013e3181ce0e4d]
27. Köbe T, Witte AV, Schnelle A, Grittner U, Tesky VA, Pantel J, Schuchardt JP, Hahn A, Bohlken J, Rujescu D, Flöel A. Vitamin B-12 concentration, memory performance, and hippocampal structure in patients with mild cognitive impairment. Am J Clin Nutr 2016; 103: 1045-1054 [PMID: 26912492 DOI: 10.3945/ajcn.115.116970]
28. Ito H, Ishida H, Takeuchi Y, Antoku S, Abe M, Mifune M, Togane M. Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus. Nutr Metab (Lond) 2010; 7: 83 [PMID: 21070671 DOI: 10.1186/1743-7075-7-83]
29. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012; 122: 253-270 [PMID: 22117616 DOI: 10.1042/CS20110386]
30. Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab 2016; 42: 316- 327 [PMID: 27130885 DOI: 10.1016/j.diabet.2016.03.008]
31. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP; Diabetes Prevention Program Research Group. Longterm Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab 2016; 101: 1754-1761 [PMID: 26900641 DOI: 10.1210/jc.2015-3754]
32. Kim J, Ahn CW, Fang S, Lee HS, Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore) 2019; 98: e17918 [PMID: 31725641 DOI: 10.1097/MD.0000000000017918]
33. Kancherla V, Elliott JL Jr, Patel BB, Holland NW, Johnson TM 2nd, Khakharia A, Phillips LS, Oakley GP Jr, Vaughan CP. Long-term Metformin Therapy and Monitoring for Vitamin B12 Deficiency Among Older Veterans. J Am Geriatr Soc 2017; 65: 1061-1066 [PMID: 28182265 DOI: 10.1111/jgs.14761]
34. Niafar M, Hai F, Porhomayon J, Nader ND. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern Emerg Med 2015; 10: 93-102 [PMID: 25502588 DOI: 10.1007/s11739-014-1157-5]
35. Liu Q, Li S, Quan H, Li J. Vitamin B12 status in metformin treated patients: systematic review. PLoS One 2014; 9: e100379 [PMID: 24959880 DOI: 10.1371/journal.pone.0100379]
36. Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformininduced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract 2012; 97: 359-367 [PMID: 22770998 DOI: 10.1016/j.diabres.2012.06.001]
37. Caspary WF, Creutzfeldt W. Analysis of the inhibitory effect of biguanides on glucoseabsorption: inhibition of active sugar transport. Diabetologia 1971 Oct;7(5):379-385.
38. Buvat DR. Use of metformin is a cause of vitamin B12 deficiency. Am Fam Physician 2004 Jan 15;69(2):264; author reply 264, 266.
39. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000 Sep;23(9):1227-1231.
40. Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123(16):1763-70.
41. Miller R.A. Chu Q.Xie J.Foretz M. Viollet B. Birnbaum M.J. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 2013; 494: 256-260.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Andrew Gnanaprakasam J
Department of Pharmacy, Annamalai University, Annamalai nagar, Chidambaram, TamilNadu, 608002, India.
Veeramani G
M.Pharm, Ph.D., Department of Pharmacy, Annamalai University, Annamalai Nagar, Chidambaram, Tamilnadu, 608002
Manjanna K
Department of Pharmacy, Annamalai University, Annamalai nagar, Chidambaram, TamilNadu, 608002, India.